Answers are grounded in this paper and cite their sources.
A large percentage of oncology clinical trials do not achieve minimum projected accruals. Trial development time appears to be one important predictor of the likelihood of successfully achieving the minimum accrual goals.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: